RBB

7 September 2002

Excess Pricing in the Napp Chapter II Case – how much is too much?

RBB Brief 5 discusses the controversial issue of excess pricing as an abuse in the context of the UK Competition Act case involving Napp Pharmaceuticals

Downloadpdf (87 KB)

Our experience and expertise means our clients have the best chance of success before competition authorities and courts.

We have unrivalled experience across the full range of issues presented by competition law and related associated litigation.

Articles

All Articles
  • Article26/02/2024
    Trouble in store(s): The CMA’s new approach to local mergers post-MAGs
  • Article20/11/2023
    RBB response to South African Commission’s draft guidelines for public interest in merger control